Literature DB >> 19414779

Follicular and marginal zone B cells fail to cross-present MHC class I-restricted epitopes derived from viral particles.

Susanne A Keller1, Caroline E von Allmen, Heather J Hinton, Monika Bauer, Simone Muntwiler, Klaus Dietmeier, Philippe Saudan, Martin F Bachmann.   

Abstract

Viruses and virus-like particles (VLPs) are known to be potent inducers of B cell as well as Th cell and CTL responses. It is well established that professional APCs such as dendritic cells (DCs) and macrophages efficiently process viral particles for both MHC class I- and MHC class II-associated presentation, which is essential for induction of CTL and Th cell responses, respectively. Less is known, however, about the ability of B cells to present epitopes derived from viral particles to T cells. Using two different VLPs, in this study we show in vitro as well as in vivo that DCs present VLP-derived peptides in association with MHC class I as well as class II. In contrast, although B cells were able to capture VLPs similarly as DCs and although they efficiently processed VLPs for presentation in association with MHC class II, they failed to process exogenous VLPs for presentation in association with MHC class I. Thus, in contrast to DCs, B cells are not involved in the process of cross-priming. This finding is of physiological importance because B cells with the ability to cross-present Ag to specific CD8(+) T cells may be killed by these cells, preventing the generation of neutralizing Ab responses.

Mesh:

Substances:

Year:  2009        PMID: 19414779     DOI: 10.4049/jimmunol.0804035

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  The role of antigen cross-presentation from leukemia blasts on immunity to the leukemia-associated antigen PR1.

Authors:  Gheath Alatrash; Yoko Ono; Anna Sergeeva; Pariya Sukhumalchandra; Mao Zhang; Lisa S St John; Tian-Hui Yang; Kathryn Ruisaard; Paul M Armistead; Elizabeth A Mittendorf; Hong He; Na Qiao; Tania Rodriguez-Cruz; Shoudan Liang; Karen Clise-Dwyer; Eric D Wieder; Gregory Lizee; Sijie Lu; Jeffrey J Molldrem
Journal:  J Immunother       Date:  2012-05       Impact factor: 4.456

2.  A virus-like particle-based Epstein-Barr virus vaccine.

Authors:  Romana Ruiss; Simon Jochum; Gerhard Wanner; Gilbert Reisbach; Wolfgang Hammerschmidt; Reinhard Zeidler
Journal:  J Virol       Date:  2011-10-12       Impact factor: 5.103

3.  Alloprimed CD8(+) T cells regulate alloantibody and eliminate alloprimed B cells through perforin- and FasL-dependent mechanisms.

Authors:  J M Zimmerer; T A Pham; C L Wright; K J Tobin; P B Sanghavi; S M Elzein; V M Sanders; G L Bumgardner
Journal:  Am J Transplant       Date:  2014-02       Impact factor: 8.086

4.  B cells promote CD8 T cell primary and memory responses to subunit vaccines.

Authors:  Jared Klarquist; Eric W Cross; Scott B Thompson; Benjamin Willett; Daniel L Aldridge; Alayna K Caffrey-Carr; Zhenming Xu; Christopher A Hunter; Andrew Getahun; Ross M Kedl
Journal:  Cell Rep       Date:  2021-08-24       Impact factor: 9.423

5.  Chimeric infectious bursal disease virus-like particles as potent vaccines for eradication of established HPV-16 E7-dependent tumors.

Authors:  Juan Martin Caballero; Ana Garzón; Leticia González-Cintado; Wioleta Kowalczyk; Ignacio Jimenez Torres; Gloria Calderita; Margarita Rodriguez; Virgínia Gondar; Juan Jose Bernal; Carlos Ardavín; David Andreu; Thomas Zürcher; Cayetano von Kobbe
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.